Corvia Medical Announces Robust Positive Data From Reduce LAP-HF I Randomized Study

Retrieved on: 2017-12-21 02:45:00

Tags for this article:

Anatomy

Circulatory system

Click the tags to see associated articles and topics

Corvia Medical Announces Robust Positive Data From Reduce LAP-HF I Randomized Study. View article details on hiswai:

Excerpt

<div>TEWKSBURY, Mass., Dec. 21, 2017 /PRNewswire/ -- Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart failure, presented primary endpoint results from the REDUCE LAP-HF I randomized study of its Interatrial ...</div>

Article found on:

View Original Article